CIK: 0001622627 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 12, 2026
Total Value ($000): $284,527 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| REPL | REPLIMUNE GROUP INC | 1,410,497 | $13,710 | 4.8% | $8.50 | 0.0% | COM | 76029N106 |
| AVBP | ARRIVENT BIOPHARMA INC | 215,871 | $4,343 | 1.5% | $20.82 | 0.0% | COM | 04272N102 |
| OKUR | ONKURE THERAPEUTICS INC | 730,488 | $2,118 | 0.7% | $2.99 | 0.0% | COM CL A | 68277Q105 |
| — | ANAVEX LIFE SCIENCES CORP | 1,168,600 | $1,881 | 0.7% | — | — | PUT | 032797950 |
| RGNT | REGENTIS BIOMATERIALS LTD | 251,510 | $1,695 | 0.6% | $6.86 | 0.0% | ORDINARY SHARES | M8211G108 |
| NRXS | NEURAXIS INC | 286,138 | $1,039 | 0.4% | $2.99 | 0.0% | COM | 64134X201 |
| — | ARRIVENT BIOPHARMA INC | 107,900 | $540 | 0.2% | — | — | CALL | 04272N902 |
| — | UNIQURE NV | 100,000 | $95 | 0.0% | — | — | CALL | N90064901 |
| — | VIKING THERAPEUTICS INC | 100,000 | $2 | 0.0% | — | — | CALL | 92686J906 |
| — | VISTAGEN THERAPEUTICS INC | 493,400 | $0 | 0.0% | — | — | CALL | 92840H900 |
| — | REPLIMUNE GROUP INC | 264,700 | $0 | 0.0% | — | — | PUT | 76029N956 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XFOR | X4 PHARMACEUTICALS INC | 2,605,920 (+68.7%) | $10,424 (+97.3%) | 3.7% | $3.01 | +20.8% | COM NEW | 98420X202 |
| PROF | PROFOUND MEDICAL CORP | 1,068,955 (+54.4%) | $8,413 (+148.5%) | 3.0% | $8.06 | -20.3% | COM NEW | 74319B502 |
| HELP | CYBIN INC | 1,657,540 (+10.5%) | $13,559 (+53.5%) | 4.8% | $8.53 | -24.5% | COM NEW | 23256X407 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 690,000 (+6.2%) | $12,606 (+36.2%) | 4.4% | $11.67 | +21.5% | COM NEW | 30233G209 |
| XERS | XERIS BIOPHARMA HOLDGS INC | 2,111,700 (+17.6%) | $16,577 (+13.4%) | 5.8% | $2.76 | +185.1% | COM | 98422E103 |
| — | INVESCO QQQ TR | 450,000 (+80.0%) | $3,029 (+94.5%) | 1.1% | — | — | PUT | 46090E953 |
| — | SPDR S&P 500 ETF TR | 510,000 (+70.0%) | $1,886 (+162.9%) | 0.7% | — | — | PUT | 78462F953 |
| FENC | FENNEC PHARMACEUTICALS INC | 2,613,508 (+25.8%) | $20,124 (+3.5%) | 7.1% | $6.23 | +31.7% | COM | 31447P100 |
| MYO | MYOMO INC | 3,839,772 (+1.3%) | $3,494 (+3.3%) | 1.2% | $3.08 | -68.9% | COM NEW | 62857J201 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RZLT | REZOLUTE INC | 1,807,202 | $16,988 | 6.0% | $3.82 | +105.2% | — | 76200L309 |
| — | VERONA PHARMA PLC | 100,000 | $10,671 | 3.8% | $20.69 | — | — | 925050106 |
| IDYA | IDEAYA BIOSCIENCES INC | 350,000 | $9,524 | 3.3% | $21.31 | +49.6% | — | 45166A102 |
| QURE | UNIQURE NV | 125,000 | $7,296 | 2.6% | $18.16 | +112.5% | — | N90064101 |
| — | ATYR PHARMA INC | 1,570,200 | $4,470 | 1.6% | — | — | PUT | 002120952 |
| — | ASTRIA THERAPEUTICS INC | 1,542,520 | $1,113 | 0.4% | $0.72 | — | — | 04635X102 |
| — | IDEAYA BIOSCIENCES INC | 35,900 | $237 | 0.1% | — | — | CALL | 45166A902 |
| — | SCHOLAR ROCK HLDG CORP | 100,000 | $10 | 0.0% | — | — | PUT | 80706P953 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | 195,045 (-51.2%) | $12,393 (-43.6%) | 4.4% | $34.78 | +78.8% | COM NEW | 23282W605 |
| GUTS | FRACTYL HEALTH INC | 385,731 (-92.3%) | $849 (-89.3%) | 0.3% | $1.30 | +24.1% | COM | 35168W103 |
| SVRA | SAVARA INC | 3,403,721 (-14.9%) | $20,524 (+43.7%) | 7.2% | $3.31 | +48.0% | COM | 805111101 |
| VSTM | VERASTEM INC | 1,788,475 (-7.3%) | $13,807 (-19.0%) | 4.9% | $5.37 | +65.9% | COM NEW | 92337C203 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 450,000 (-25.0%) | $14,004 (+8.2%) | 4.9% | $16.51 | +66.1% | COM | 92790C104 |
| — | VERASTEM INC | 268,600 (-58.5%) | $160 (-82.2%) | 0.1% | — | — | CALL | 92337C903 |
| — | SPDR SERIES TRUST | 1,937,600 (-9.0%) | $1,348 (+41.8%) | 0.5% | — | — | PUT | 78464A950 |
| — | REPLIMUNE GROUP INC | 230,900 (-54.8%) | $12 (-93.7%) | 0.0% | — | — | CALL | 76029N906 |
| TLPH | TALPHERA INC | 3,579,273 (-18.4%) | $4,080 (+4.2%) | 1.4% | $0.60 | +101.8% | COM NEW | 00444T209 |
| PYPD | POLYPID LTD | 696,556 (-24.2%) | $3,023 (-1.3%) | 1.1% | $4.49 | -17.2% | COM | M8001Q126 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ATYR | ASTRIA THERAPEUTICS INC | 1,039,080 | $13,602 | 4.8% | $4.53 | -81.9% | COM | 002120202 |
| NSPR | INSPIREMD INC | 3,905,743 | $6,952 | 2.4% | $2.46 | -15.4% | COM | 45779A846 |
| — | MIND MEDICINE MINDMED INC | 750,000 | $10,043 | 3.5% | $8.46 | — | COM NEW | 60255C885 |
| — | ISHARES TR | 200,000 | $1,112 | 0.4% | — | — | PUT | 464287955 |
| — | REZOLUTE INC | 263,100 | $0 | 0.0% | — | — | CALL | 76200L909 |
| BFRI | BIOFRONTERA INC | 1,140,764 | $650 | 0.2% | $1.02 | -11.4% | COM NEW | 09077D209 |
| CGON | CG ONCOLOGY INC | 300,000 | $12,456 | 4.4% | $25.87 | +59.9% | COM | 156944100 |
| TRVI | TREVI THERAPEUTICS INC | 100,000 | $1,252 | 0.4% | $2.31 | +400.6% | COM | 89532M101 |
| MDWD | MEDIWOUND LTD | 749,054 | $13,828 | 4.9% | $14.40 | +26.9% | SHS NEW | M68830112 |
| OCUL | Ocular Therapeutix, Inc | 400,000 | $4,856 | 1.7% | $7.23 | +68.0% | COM | 67576A100 |
| KURA | KURA ONCOLOGY INC | 100,000 | $1,039 | 0.4% | $7.79 | +34.6% | COM | 50127T109 |
| DCTH | DELCATH SYSTEMS, INC. | 3,300,389 | $33,004 | 11.6% | $6.89 | +44.3% | COM NEW | 24661P807 |